Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease
Some experimental studies have suggested a beneficial effect of the mammalian target of rapamycin (mTOR) inhibitor use on hepatic and renal cyst growth in patients with autosomal dominant polycystic kidney disease (ADPKD). However, the results of clinical studies are conflicting and the role of mTOR...
Saved in:
Main Authors: | L. Friedrich, F. Barbey, M. Pascual, J.-P. Venetz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2012/513025 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Unusual Cardiac Manifestation in Autosomal Dominant Polycystic Kidney Disease
by: Fausta Catapano, et al.
Published: (2012-01-01) -
Increased Apoptosis and Proliferative Capacity are Early Events in Cyst Formation in Autosomal-Dominant, Polycystic Kidney Disease
by: Salwa Ibrahim
Published: (2007-01-01) -
Differential Expression of -Associated Genes in Autosomal Dominant Polycystic Kidney Disease
by: Yeon Joo Yook, et al.
Published: (2012-03-01) -
Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease
by: Christopher M. Blanchette, et al.
Published: (2014-07-01) -
Nephrotic Syndrome and Idiopathic Membranous Nephropathy Associated with Autosomal-Dominant Polycystic Kidney Disease
by: Ramón Peces, et al.
Published: (2011-01-01)